Search

The reduction of protochlorophyllide (Pchlide) to chlorophyllide (Chlide) is the penultimate step of chlorophyll biosynthesis. In oxygenic photosynthetic bacteria, algae, and plants, this reaction can be catalyzed by the light-dependent Pchlide oxidoreductase (LPOR), a member of the short-chain dehydrogenase superfamily sharing a conserved Rossmann fold for NAD(P)H binding and the catalytic activity. Whereas modeling and simulation approaches have been used to study the catalytic mechanism of this light-driven reaction, key details of the LPOR structure remain unclear. We determined the crystal structures of LPOR from two cyanobacteria, Synechocystis sp. PCC 6803 and Thermosynechococcus elongatus . Structural analysis defines the LPOR core fold, outlines the LPOR–NADPH interaction network, identifies the residues forming the substrate cavity and the proton-relay path, and reveals the role of the LPOR-specific loop. These findings provide a basis for understanding the structure-function relationships of the light-driven Pchlide reduction.

We report the synthesis of Pt-Sn binary and Pt-Ru-Sn ternary alloy nanoparticles (NPs) dispersed on mesoporous carbon CMK-3 for bioalcohol fuel cell applications where ethanol, ethylene glycol, and fermentative hydrogen production effluent were used as the fuels. The proposed alloy electrocatalysts, denoted as Pt 20 Ru x Sn y @C (where 20, x, and y represent the weight fractions of Pt, Ru, and Sn, respectively), were examined using scanning electron microscopy, energy-dispersive X-ray spectroscopy mapping, transmission electron microscopy, Brunauer-Emmett-Teller measurements, X-ray diffraction analysis, and electrochemical measurements, in order to determine their morphologies, microstructures, compositions, phase structures, and electrochemical characteristics. The effects of the Sn content on the following factors were examined: 1) average particle size of the alloy NPs, 2) mesoporosity, 3) electrochemically active surfaces of Pt 20 Ru x Sn y @C, and 4) ethanol oxidation reaction and ethylene glycol oxidation reaction activities. Higher Sn contents improved the catalytic efficiency of Pt 20 Ru x Sn y when x = 0 or x = 10, with the optimized compositions being Pt 20 Sn 30 and Pt 20 Ru 10 Sn 15 for the binary and ternary alloys, respectively. Based on the ethanol and ethylene glycol oxidation reactions, we explain the role of Sn in promoting C C bond cleavage and in improving catalyst tolerance against poisoning. Overall, for both the ethanol system and the ethylene glycol system, the catalytic activities could be arranged as follows: Pt 20 Ru 10 Sn 15 @C > Pt 20 Sn 30 @C > Pt 20 Ru 10 @C > Pt 20 @C. The chronoamperometric measurement shows that Pt 20 Ru 10 Sn 15 @C is more stable than commercial E-TEK Pt/C catalyst under ethanol environment. Finally, the catalyst Pt 20 Ru 10 Sn 15 was used successfully to demonstrate the feasibility of using the bioalcohol from a fermentation effluent as a fuel.

The discovery of an emerging viral disease, severe fever with thrombocytopenia syndrome (SFTS), caused by SFTS virus (SFTSV), has prompted the need to understand pathogenesis of SFTSV. We are unique in establishing an infectious model of SFTS in C57/BL6 mice, resulting in hallmark symptoms of thrombocytopenia and leukocytopenia. Viral RNA and histopathological changes were identified in the spleen, liver, and kidney. However, viral replication was only found in the spleen, which suggested the spleen to be the principle target organ of SFTSV. Moreover, the number of macrophages and platelets were largely increased in the spleen, and SFTSV colocalized with platelets in cytoplasm of macrophages in the red pulp of the spleen. In vitro cellular assays further revealed that SFTSV adhered to mouse platelets and facilitated the phagocytosis of platelets by mouse primary macrophages, which in combination with in vivo findings, suggests that SFTSV-induced thrombocytopenia is caused by clearance of circulating virus-bound platelets by splenic macrophages. Thus, this study has elucidated the pathogenic mechanisms of thrombocytopenia in a mouse model resembling human SFTS disease.

SFTS virus (SFTSV) is a highly pathogenic bunyavirus that causes severe fever with thrombocytopenia syndrome (SFTS), an emerging infectious disease in China. Laboratory mice have been reported to be susceptible to SFTSV infection, but the infection in nonhuman primates has not been investigated. This study is the first to report that, in rhesus macaques, SFTSV does not cause severe symptoms or death but causes fever, thrombocytopenia, leukocytopenia, and increased levels of transaminases and myocardial enzymes in blood. Viremia, virus-specific immunoglobulin M and immunoglobulin G antibodies, and neutralizing antibodies were identified in all infected macaques. Levels of the cytokines interferon γ, eotaxin, tumor necrosis factor α, and macrophage inflammatory protein 1β were significantly elevated in the blood. Minor pathological lesions were observed in the liver and kidney during the late stages of infection. Overall, SFTSV infection in rhesus macaques resembled mild SFTS in humans.

Interleukin-21 (IL-21) is produced primarily by CD4+ T cells and regulates immunity against human/simian immunodeficiency virus (HIV/SIV) infection. Activated CD8+ cells and their secreted interferon-gamma (IFN- γ) are crucial for the control of acute HIV/SIV infection. However, whether IL-21 can regulate IFN- γ production by CD8+ cells remains controversial. Rhesus macaques (RMs, n = 8) were infected with SHIV and the levels of plasma IL-21, IFN- γ and the frequency of peripheral blood activated T cells were measured longitudinally. Following infection with SHIV, the levels of plasma IL-21 and IFN- γ increased, peaked at 17 days postinfection and declined later. Furthermore, IL-21 induced IL-21 receptor (IL-21R) and IFN- γ, perforin, but not granmyze B, expression in CD8+ cells from four selected SHIV-infected RMs. The regulatory effect of IL-21 on CD8+ cell function appeared to be associated with increased levels of STAT3, but not STAT5, phosphorylation in CD8+ cells from SHIV-infected RMs. In parallel, treatment with soluble IL-21R/Fc, an inhibitor of IL-21-induced activation of JAK1/3 and STAT3, abrogated IL-21-induced STAT3 activation and IFN- γ production in CD8+ cells from SHIV-infected RMs in vitro. Our data indicated that IL-21 was a positive regulator of IFN- γ-secreting CD8+ cells and increased the STAT3 phosphorylation, regulating T-cell immunity against acute SHIV infection in RMs. Our findings may provide a new basis for the development of immunotherapies for the control of SHIV/HIV infection.